Author Correction: Gut microbiome structure and metabolic activity in inflammatory bowel disease

Eric A Franzosa^#^{1

2}, Alexandra Sirota-Madi^#¹, Julian Avila-Pacheco¹, Nadine Fornelos¹, Henry J Haiser³, Stefan Reinker³, Tommi Vatanen¹, A Brantley Hall¹, Himel Mallick^{1

2}, Lauren J McIver^{1

2}, Jenny S Sauk⁴, Robin G Wilson⁴, Betsy W Stevens⁴, Justin M Scott¹, Kerry Pierce¹, Amy A Deik¹, Kevin Bullock¹, Floris Imhann^{5

6}, Jeffrey A Porter⁷, Alexandra Zhernakova⁶, Jingyuan Fu^{6

8}, Rinse K Weersma⁵, Cisca Wijmenga^{6

9}, Clary B Clish¹, Hera Vlamakis¹, Curtis Huttenhower^{10

11}, Ramnik J Xavier^{12

13

14}

Affiliations

¹ Broad Institute of MIT and Harvard, Cambridge, MA, USA.
² Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA.
³ Novartis Institute for Biomedical Research Inc, Cambridge, MA, USA.
⁴ Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
⁵ Department of Gastroenterology and Hepatology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
⁶ Department of Genetics, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
⁷ Novartis Institute for Biomedical Research Inc, Basel, Switzerland.
⁸ Department of Pediatrics, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
⁹ Department of Immunology, K.G. Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, Norway.
¹⁰ Broad Institute of MIT and Harvard, Cambridge, MA, USA. chuttenh@hsph.harvard.edu.
¹¹ Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA. chuttenh@hsph.harvard.edu.
¹² Broad Institute of MIT and Harvard, Cambridge, MA, USA. xavier@molbio.mgh.harvard.edu.
¹³ Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. xavier@molbio.mgh.harvard.edu.
¹⁴ Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology, Cambridge, MA, USA. xavier@molbio.mgh.harvard.edu.

^# Contributed equally.

PMID: 30971771
DOI: 10.1038/s41564-019-0442-5

Published Erratum

Author Correction: Gut microbiome structure and metabolic activity in inflammatory bowel disease

Eric A Franzosa et al. Nat Microbiol. 2019 May.

. 2019 May;4(5):898.

doi: 10.1038/s41564-019-0442-5.

Authors

Affiliations

¹ Broad Institute of MIT and Harvard, Cambridge, MA, USA.
² Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA.
³ Novartis Institute for Biomedical Research Inc, Cambridge, MA, USA.
⁴ Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
⁵ Department of Gastroenterology and Hepatology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
⁶ Department of Genetics, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
⁷ Novartis Institute for Biomedical Research Inc, Basel, Switzerland.
⁸ Department of Pediatrics, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
⁹ Department of Immunology, K.G. Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, Norway.
¹⁰ Broad Institute of MIT and Harvard, Cambridge, MA, USA. chuttenh@hsph.harvard.edu.
¹¹ Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA. chuttenh@hsph.harvard.edu.
¹² Broad Institute of MIT and Harvard, Cambridge, MA, USA. xavier@molbio.mgh.harvard.edu.
¹³ Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. xavier@molbio.mgh.harvard.edu.
¹⁴ Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology, Cambridge, MA, USA. xavier@molbio.mgh.harvard.edu.

^# Contributed equally.

PMID: 30971771
DOI: 10.1038/s41564-019-0442-5

Abstract

In the Supplementary Tables 2, 4 and 6 originally published with this Article, the authors mistakenly included sample identifiers in the form of UMCGs rather than UMCG IBDs in the validation cohort; this has now been amended.

PubMed Disclaimer

Erratum for

Gut microbiome structure and metabolic activity in inflammatory bowel disease.
Franzosa EA, Sirota-Madi A, Avila-Pacheco J, Fornelos N, Haiser HJ, Reinker S, Vatanen T, Hall AB, Mallick H, McIver LJ, Sauk JS, Wilson RG, Stevens BW, Scott JM, Pierce K, Deik AA, Bullock K, Imhann F, Porter JA, Zhernakova A, Fu J, Weersma RK, Wijmenga C, Clish CB, Vlamakis H, Huttenhower C, Xavier RJ. Franzosa EA, et al. Nat Microbiol. 2019 Feb;4(2):293-305. doi: 10.1038/s41564-018-0306-4. Epub 2018 Dec 10. Nat Microbiol. 2019. PMID: 30531976 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Gut microbiome structure and metabolic activity in inflammatory bowel disease

Affiliations

Author Correction: Gut microbiome structure and metabolic activity in inflammatory bowel disease

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources